The reduced neuropil hypothesis: A circuit based model of schizophrenia

Biological Psychiatry

Volumn 45, Issue 1, 1999, Pages 17-25

  Selemon, Lynn D ^a   Goldman Rakic, Patricia S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Frontal; Human; Morphometry; Neuropathology; Postmortem

Indexed keywords

CALRETININ; GLUTAMATE DECARBOXYLASE; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN 2; N ACETYLASPARTIC ACID; PARVALBUMIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE DEHYDROGENASE; SYNAPTOPHYSIN;

BRAIN CORTEX; CELL DENSITY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUNTINGTON CHOREA; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MODEL; MORPHOMETRICS; NEUROPIL; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

BRAIN; CELL COUNT; HUMANS; NEURONS; NEUROPIL; SCHIZOPHRENIA;

EID: 0032967531     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(98)00281-9     Document Type: Review

References (93)

1. Akbarian S., Bunney W.E. Jr, Potkin S.G., et al. Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenic implies disturbances of cortical development. Arch Gen Psychiatry. 50:1993;169-177.
2. Akbarian S., Kim J.J., Potkin S.G., et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 52:1995;258-266.
3. Akil M., Lewis D.A. Reduced dopaminergic innervation of the prefrontal cortex in schizophrenia. Soc Neurosci Abst. 22:1996;1679.
4. Anderson S.A., Volk D.A., Lewis D.A. Increased density of microtubule associated protein 2-immunoreactive neurons in the prefrontal white matter of schizophrenic subjects. Schizophr Res. 19:1996;111-119.
5. Andreasen N.C. Brain imaging: Applications in psychiatry. Science. 239:1988;1381-1388.
6. Andreasen N.C., Arndt S., Swayze V. II, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance imaging. Science. 266:1994;294-298.
7. Andreasen N.C., Flashman L., Flaum M., et al. Regional brain abnormalities in schizophrenia measure with magnetic resonance imaging. JAMA. 272:1994;1763-1769.
8. Andreasen N.C., O'Leary D.S., Flaum M., et al. Hypofrontality in schizophrenia: Distributed dysfunctional circuits in neuroleptic naive patients. Lancet. 349:1997;1730-1734.
9. Arnold S.E., Franz B.R., Gur R.C., et al. Smaller neuron size in schizophrenia in hippocampal subfields that mediate cortical-hippocampal interactions. Am J Psychiatry. 152:1995;738-748.
10. Arnsten A.F.T., Cai J.X., Murphy B.L., Goldman-Rakic P.S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology. 116:1994;143-151.
11. Beasley C.L., Reynolds G.P. Parvalbumin-immunoreactive neurons are reduced in the prefrontal cortex of schizophrenics. Schizophr Res. 24:1997;349-355.
12. Benes F.M. The role of stress and dopamine-GABA interactions in the vulnerability for schizophrenia. J Psychiat Res. 31:1997;257-275.
13. Benes F.M. Neurobiological investigations in cingulate cortex of schizophrenic brain. Schizophr Res. 19:1993;537-549.
14. Benes F.M., Davison J., Bird E.D. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Arch Gen Psychiatry. 43:1986;31-35.
15. Benes F.M., Kwok E.W., Vincent S.L., Todtenkopf M.S. A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry. 44:1998;88-97.
16. Benes F.M., McSparren J., Bird E.D., SanGiovanni J.P., Vincent S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry. 48:1991;996-1001.
17. Benes FM (1998) Post-mortem structural analyses of schizophrenic brain. Study designs and the interpretation of data. Psychiatric Developments 6:213-226.
18. Benes F.M., Todtenkopf M.S., Taylor J.B. A shift in tyrosine hydroxlase-immunoreactive varicosities (TH-IRv) from pyramidal (PN) to nonpyramidal (NP) neurons occurs in layer II of the anterior cingulate cortex of schizophrenics. Soc Neurosci Abst. 21:1995;259.
19. A receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience. 75:1996;1021-1031.
20. A receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci. 12:1992;924-929.
21. Bertolino A., Callicott J.H., Elman I., et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: A proton magnetic resonance spectroscopic study. Biol Psychiatry. 43:1997;641-648.
22. Bertolino A., Nawroz S., Mattay V.S., et al. Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging. Am J Psychiatry. 153:1996;1554-1563.
23. Bogerts B. Recent advances in the neuropathology of schizophrenia. Schizophr Bull. 19:1993;431-445.
24. Braendgaard H., Gundersen H.J.G. The impact of recent stereological advances on quantitative studies of the nervous system. J Neurosci Meth. 18:1986;39-78.
25. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr Bull. 19:1993;233-259.
26. Breier A., Buchanan W., Elkashef A., Munson R.C., Kirkpatrick B., Gellard F. Brain morphology and schizophrenia. A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Arch Gen Psychiatry. 49:1994;921-926.
27. Brown R., Colter N., Corsellis J.A.N., et al. Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry. 43:1986;36-42.
28. Buchsbaum M.S., Someya T., Teng C.Y., et al. PET and MRI of thalamus in never-medicated patients with schizophrenia. Am J Psychiatry. 153:1996;191-199.
29. Cannon T.D., Marco E. Structural brain abnormalities as indicators of vulnerability to schizophrenia. Schizophr Bull. 20:1994;89-101.
30. Chua S.E., Murray R.M. The neurodevelopmental theory of schizophrenia: Evidence concerning structure and neurophysiology. Ann Med. 28:1996;547-555.
31. Crow T.J. Is schizophrenia the price that homo sapiens pays for language? Schizophr Res. 28:1997;127-141.
32. Crow T.J. Schizophrenia as a failure of hemispheric dominance for language. Trend Neurosci. 20:1997;339-343.
33. Crow T.J. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophr Bull. 16:1990;433-443.
34. Crow T.J., Ball J., Bloom S.R., et al. Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry. 46:1989;1145-1150.
35. Daviss S.R., Lewis D.A. Local circuit neurons of the prefrontal cortex in schizophrenia: Selective increase in the density of calbindin-immunoreactive neurons. Psychiatry Res. 59:1995;81-96.
36. Dwork A.J. Postmortem studies of the hippocampal formation in schizophrenia. Schizophr Bull. 23:1997;385-402.
37. Eastwood S.L., Burnet P.W.J., Harrison P.J. Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience. 66:1995;309-319.
38. Falkai P., Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 236:1986;154-161.
39. Farber N.B., Wozniak D.F., Price M.T., et al. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: Potential relevance to schizophrenia? Soc Biol Psychiatry. 38:1995;788-796.
40. Feinberg I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiat Res. 17:1982;319-330.
41. Fletcher P.C., Frith C.D., Grasby P.M., Friston K.J., Dolan R.J. Local and distributed effects of apomorphine on fronto-temporal function in acute unmedicated schizophrenia. J Neurosci. 16:1996;7055-7062.
42. Friston K.J., Frith C.D. Schizophrenia: A disconnection syndrome? Clin Neurosci. 3:1995;89-97.
43. Frith C.D., Friston K.J., Liddle P.F., Frackowiak R.S. Willed action and the prefrontal cortex in man. Proc R Sec Lend (B). 244:1991;241-246.
44. Garey L.J., Ong W.Y., Patel T.S., et al. Reduction in dendritic spine number on cortical pyramidal neurons in schizophrenia. Soc Neurosci Abst. 21:1995;237.
45. Glantz L.A., Lewis D.A. Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry. 54:1997;943-952.
46. Glantz L.A., Lewis D.A. Assessment of spine density on layer III pyramidal cells in the prefrontal cortex of schizophrenic subjects. Soc Neurosci Abst. 21:1995;239.
47. Goldman-Rakic P.S. Cellular basis of working memory. Neuron. 14:1995;477-485.
48. Goldman-Rakic P.S. Prefrontal cortical dysfunction in schizophrenia: The relevance of working memory. Carroll B.J., Barrett J.E. Psychopathology and the Brain. 1991;1-23 Raven Press, New York.
49. Goldman-Rakic P.S., Selemon L.D. Functional and anatomical aspects of prefrontal pathology in schizophrenia. Schizophr Bull. 23:1997;437-458.
50. Harrison P.J. Schizophrenia: A disorder of neurodevelopment? Current Opin Neurobiol. 7:1997;285-289.
51. Heckers S. Neuropathology of schizophrenia. Schizophr Bull. 23:1997;403-422.
52. Heckers S., Heinsen H., Geiger B., Beckmann H. Hippocampal neuron number in schizophrenia. A stereological study. Arch Gen Psychiatry. 48:1991;1002-1008.
53. Hollinger D.P., Mori C., Galaburda A.M. Schizophrenia: Neuronal measures in left and right language and visual cortices. Soc Neurosci Abst. 23:1997;2198.
54. Hollinger D.P., Rosen G.D., Galaburda A.M. Decreased neuronal density in supragranular layers of area TPT of the superior temporal gyrus of schizophrenics. Soc Neurosci Abst. 21:1995;238.
55. Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1991;1301-1308.
56. Jeste D.V., Lohr J.B. Hippocampal pathologic findings in schizophrenia: A morphometric study. Arch Gen Psychiatry. 46:1989;1019-1024.
57. Joyce J.N., Meador-Woodruff J.H. Linking the family of D2 receptors to neuronal circuits in human brain: Insight into schizophrenia. Neuropsychopharmacol. 16:1997;375-384.
58. Kovelman J.A., Scheibel A.B. A neurohistological correlate of schizophrenia. Biol Psychiatry. 19:1984;1601-1621.
59. Krimer L., Herman M.M., Saunders R.C., et al. A qualitative and quantitative analysis of the entorhinal cortex in schizophrenia. Cereb Cortex. 7:1997;732-739.
60. Krystal J.H., Karper L.P., Seibyl J.P., et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: Psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch Gen Psychiatry. 51:1994;199-214.
61. Lewis D.A., Woo T.-U., Miller J.L., Soloway A.S. Schizophrenia and subclasses of local circuit neurons in the prefrontal cortex. Schizophr Res. 24:1997;38-39.
62. Liddle P.F., Friston K.J., Frith C.D., Hirsch S.R., Jones T., Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia. Br J Psychiatry. 160:1992;179-186.
63. Lim K.O., Tew W., Kushner M., Chow K., Matsumoto B., DeLisi L.E. Cortical gray matter volume deficit in patients with first episode schizophrenia. Am J Psychiatry. 153:1996;1548-1553.
64. Okubo Y., Suhara T., Suzuki K., et al. Decreased prefrontal D1 receptors in schizophrenia revealed by PET. Nature. 385:1997;634-635.
65. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 52:1995;998-1007.
66. Pakkenberg B. Total nerve cell number in neocortex in chronic schizophrenic and controls estimated using optical disectors. Biol Psychiatry. 34:1993;768-772.
67. Pakkenberg P. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry. 47:1990;1023-1028.
68. Pakkenberg B. Post-mortem study of chronic schizophrenic brains. Brit J Psychiatry. 151:1987;744-752.
69. Pettegrew J.W., Keshavan M.S., Panchalingam K., et al. Alterations in brain high-energy phosphate and membrain phospholipid metabolism in first-episode, drug-naive schizophrenics: A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy. Arch Gen Psychiatry. 48:1991;563-568.
70. Plum F. Neuropathological findings. Neurosci Res Prog Bull. 10:1972;384-388.
71. Portas C.M., Goldstein J.M., Shenton M.E., et al. Volumetric evaluation of the thalamus in schizophrenic male patients using magnetic resonance imaging. Biol Psychiatry. 43:1998;649-659.
72. Rajkowska G., Selemon L.D., Goldman-Rakic P.S. Neuronal and glial somal size in the prefrontal cortex: A post-mortem study of schizophrenia and Huntington's disease. Arch Gen Psychiatry. 55:1998;215-224.
73. Roberts G.W., Crow T.J. The neuropathology of schizophrenia - A progress report. Brit Med Bull. 43:1987;599-615.
74. Roberts R.C., Conley R., Kung L., Peretti F.J., Chute D.J. Reduced striatal spine size in schizophrenia: A postmortem ultrastructural study. Neuroreport. 7:1996;1214-1218.
75. Sedvall G., Farde L. Dopamine receptors in schizophrenia. Lancet. 347:1996;264.
76. Selemon L.D., Rajkowska G. Deep layer degeneration in prefrontal cortical area 46 in advanced-stage Huntington's diseased brains. Soc Neurosci Abst. 23:1997;1912.
77. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a 3-dimensional, stereologic counting method. J Comp Neurol. 392:1998;402-412.
78. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Abnormally high neuronal density in the schizophrenic cortex: A morphometric analysis of prefrontal area 9 and occipital area 17. Arch Gen Psychiatry. 52:1995;805-818.
79. Shapiro R.M. Regional neuropathology in schizophrenia: Where are we? Where are we going? Schizophr Res. 10:1993;187-239.
80. Smiley J.F., Levey A.I., Ciliax B.J., Goldman-Rakic P.S. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: Predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA. 91:1994;5720-5724.
81. Sullivan E.V., Shear P.K., Lim K.O., Zipursky R.B., Pfefferbaum A. Cognitive and motor impairments are related to gray matter volume deficits in schizophrenia. Biol Psychiatry. 39:1996;234-240.
82. Ward K.E., Friedman L., Wise A., Schulz S.C. Meta-analysis of brain and cranial size in schizophrenia. Schizophr Res. 22:1996;197-213.
83. Weinberger D.R. Implications for normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiat. 44:1987;660-669.
84. Weinberger D.R., Berman K.F., Suddath R., Torrey E.F. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: A magnetic resonance imaging and regional blood flow study of discordant monozygotic twins. Am J Psychiatry. 149:1992;890-897.
85. Weinberger D.R., Wyatt R.J. Brain morphology in schizophrenia: In vivo studies. Henn F., Nasrallah H. Schizophrenia as a Brain Disease. 1982;148-175 Oxford Univ Press, Oxford.
86. Weinberger D.R., Wyatt R.L., Wyatt R.J. Neuropathological studies of schizophrenia: A selective review. Schizophr Bull. 9:1983;193-212.
87. West M.J. New stereological methods for counting neurons. Neurobiol Aging. 14:1993;275-285.
88. Williams G.V., Goldman-Rakic P.S. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature. 376:1995;572-575.
89. Williams R.W., Rakic P. Three-dimensional counting: An accurate and direct method to estimate numbers of cells in sectioned material. J Comp Neurol. 278:1988;344-352.
90. Woo T.-U., Miller J.L., Lewis D.A. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. Am J Psychiatry. 154:1997;1013-1015.
91. Woo T.-U., Whitehead R.E., Melchitzky D.S., Lewis D.A. A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA. 95:1998;5341-5346.
92. Zaidel D.W., Esiri M.M., Harrison P.J. The hippocampus in schizophrenia: Lateralized increase in neuronal density and altered cytoarchitectural asymmetry. Psychol Med. 27:1997;703-713.
93. Zipursky R.B., Lim K.O., Sullivan E.V., Brown B.W., Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry. 42:1992;195-205.